Molecular Profiling and Clinical Outcomes in Patients with In-Transit Recurrence of Melanoma

被引：0
|
作者：
Farma, J. [1 ]
Kulkarni, N. [1 ]
Escalante, D. A. [2 ]
Meade, C. [2 ]
Osevala, N. [2 ]
Zibelman, M. [1 ]
Gustafson, K. S. [1 ]
Wu, H. [1 ]
Lango, M. [1 ]
Reddy, S. [1 ]
Movva, S. [1 ]
Olszanski, A. J. [1 ]
Zih, F. S. [1 ]
机构：
[1] Fox Chase Canc Ctr, Surg Oncol, Philadelphia, PA 19111 USA
[2] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P264
引用
收藏
页码：S131 / S132
页数：2
相关论文
共 50 条
  • [41] In-transit recurrence after sentinel lymph node biopsy in melanoma: Primum non nocere
    Coit, DG
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (08) : 575 - 578
  • [42] The European approach to in-transit melanoma lesions
    Hoekstra, H. J.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2008, 24 (03) : 227 - 237
  • [43] Topical and intralesional therapies for in-transit melanoma
    Henderson, Michael A.
    MELANOMA MANAGEMENT, 2019, 6 (03)
  • [44] In-transit melanoma metastases of the scrotum with unusual clinical-dermoscopic features
    Manganoni, Ausilia M.
    Pavoni, Laura
    Gualdi, Giulio
    Calzavara-Pinton, Piergiacomo
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2016, 151 (03): : 322 - 323
  • [45] Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases
    Hsueh, EC
    Nathanson, L
    Foshag, LJ
    Essner, R
    Nizze, JA
    Stern, SL
    Morton, DL
    CANCER, 1999, 85 (10) : 2160 - 2169
  • [46] Checkpoint inhibitor treatment in patients with isolated in-transit melanoma metastases.
    Storey, Lucy
    Abdul-Latif, Mohammed
    Kreft, Sophia
    Barrett, Emma
    Pickering, Lisa M.
    Rohaan, Maartje W.
    Ahmed, Sobia
    Eigentler, Thomas K.
    Hassel, Jessica Cecile
    Haferkamp, Sebastian
    Meiss, Frank
    Steeb, Theresa
    Shaw, Heather May
    Blank, Christian U.
    Van Akkooi, Alexander Christopher Jonathan
    Larkin, James M. G.
    Schilling, Bastian
    Lorigan, Paul
    Nathan, Paul D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma
    Molenkamp, BG
    Muller, MGS
    Vuylsteke, RJCLM
    van der Sijp, JRM
    Meijier, S
    van Leeuwen, PAM
    EJSO, 2005, 31 (02): : 211 - 212
  • [48] Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma
    Thomas, JM
    Clark, MA
    EJSO, 2004, 30 (06): : 686 - 691
  • [49] Individualized Local Treatment Strategies for In-Transit Melanoma
    Terando, Alicia M.
    Carson, William E., III
    ONCOLOGY-NEW YORK, 2011, 25 (14): : 1355 - 1360
  • [50] Efficacy of immune checkpoint inhibitors for in-transit melanoma
    Nan Tie, Emilia
    Lai-Kwon, Julia
    Rtshiladze, Michael Alexander
    Na, Lumine
    Bozzi, James
    Read, Tavis
    Atkinson, Victoria
    Au-Yeung, George
    Long, Georgina
    McArthur, Grant A.
    Sandhu, Shahneen
    Saw, Robyn
    Walpole, Euan
    Menzies, Alexander
    Smithers, Mark
    Gyorki, David E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345